Mar 3, 2026 07:22AM
Mar 2, 2026 05:37PM
Mar 2, 2026 02:37PM
Mar 2, 2026 07:30AM
Feb 22, 2026 04:00PM
Feb 22, 2026 04:00PM
Jan 20, 2026 07:30AM Dyne Therapeutics receives orphan drug designation in Japan for DM1 treatment
Jan 20, 2026 07:30AM
Dec 23, 2025 07:30AM
Dec 23, 2025 07:30AM
Dec 9, 2025 07:40AM
Dec 8, 2025 07:40AM
Dec 8, 2025 06:30AM
Dec 8, 2025 06:30AM Dyne Therapeutics Announces Positive Topline Results from Phase 1/2 DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
Nov 16, 2025 03:00PM
Nov 5, 2025 04:10PM
Oct 24, 2025 08:29AM
Oct 6, 2025 06:01PM
Oct 6, 2025 06:01PM
Oct 2, 2025 04:05PM
Oct 2, 2025 04:05PM Dyne Therapeutics Appoints Brian Posner to its Board of Directors
Sep 29, 2025 08:35AM
Sep 29, 2025 08:35AM
Sep 11, 2025 08:18AM
Aug 4, 2025 08:31AM
Aug 4, 2025 07:30AM
Aug 4, 2025 07:30AM
Jul 28, 2025 04:10PM Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Jul 6, 2025 10:00AM
Jul 1, 2025 10:00AM
Jun 30, 2025 04:02PM
Jun 30, 2025 04:01PM
Jun 28, 2025 10:00AM
Jun 23, 2025 11:52AM
Jun 18, 2025 10:25AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
Jun 18, 2025 06:43AM
Jun 17, 2025 09:39AM
Jun 17, 2025 07:01AM
Jun 17, 2025 07:00AM
Jun 5, 2025 12:44PM
Jun 5, 2025 07:30AM
May 13, 2025 02:22PM Stifel Reiterates Buy Rating on Dyne Therapeutics (DYN), PT $66
May 12, 2025 06:57AM
May 8, 2025 07:30AM
Apr 24, 2025 07:32AM
Apr 24, 2025 07:30AM
Apr 15, 2025 07:31AM
Apr 15, 2025 07:30AM
Mar 26, 2025 05:58AM BMO Capital Reiterates Outperform Rating on Dyne Therapeutics (DYN)
Mar 20, 2025 04:25PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All